Access to medicines director at Public Citizen, board at Medicines Patent Pool. Lawyer (citizen.org/access), songwriter (maybarduk.com). Maia’s dad.
Peter Maybarduk
Loading...
“We encourage CEPI to strengthen & disclose terms relevant for equity, including licensing, step-in rights, supply, price; to adopt broader formal LMIC and civil-society participation in oversight … and to support systematically regional manufacturing ecosystems.
Peter Maybarduk
“Access requirements are now spreading among research funders, who are convening to discuss how to coordinate their policies to grantees …
“Access provisions will spread more rapidly if they are public … & can then act as a baseline from which funders can collectively raise their requirements."
"CEPI indicates that it is reviewing its access policy and exploring greater transparency as it prepares to implement its new strategy. The question remains whether any changes will be incremental or norm-setting.
"… The Trump administration has kept details of the proposed agreements—and even signed accords—secret, although some apparent drafts have circulated online.”
“Zimbabwe, Ghana & Zambia have said no or dragged out negotiations over the Trump administration’s self-described America First foreign-assistance policies, which aim to tie health aid more directly to U.S. diplomatic and security goals.
We also are working with African & global experts to support countries speaking up about unfair terms. Countries need these health agreements after the cuts. But that doesn't mean we accept the Trump’s extractivism or efforts to divide and conquer the partners of the United States.
We spoke with WSJ for this excellent piece about African states pushing back against Trump’s extractive deals.
"Public Citizen, a Washington-based consumer group, has sued the State Department in an effort to force release of the details. The federal suit is pending.”
www.wsj.com/world/africa...
www.thelancet.com/journals/lan...
Reluctance to publish contract terms has reduced health funding accountability. “Despite long-standing stakeholder concerns related to insufficient transparency, CEPI's underlying approach has not substantively changed …
Vax investment should be transparent, especially access terms. CEPI committed $50m to Moderna for Ebola, but has not published the terms. CEPI “should be judged above all by its access mission, because that is what distinguishes it from a conventional innovation fund.” Our comment in The Lancet:
